Click on a filter below to refine your search. Remove a filter to broaden your search.
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
A decreased use of insulin and sulfonylureas was seen postintervention.
Estimated mean change from baseline in HbA1c was −2.1% with tirzepatide, which met noninferiority criteria and achieved superiority.